Skip to main content

Table 2 Laboratory investigations in case 2

From: COVID-19 and emergencies in patients with diabetes: two case reports

Hemoglobin g/dl [range: 14–18]

11.3

11.4

10.5

9.1

11

9.2

Hematocrit, % [range: 40–54]

34

30

33

28

34.2

27

Leukocytes, 103/ml [range: 5.0–10.0]

8.37

7.71

14.7

15.5

11.2

11.0

Neutrophils, % [range: 45–74]

70.1

63.4

91.7

93

82.2

80

Lymphocytes, % [range: 16–45]

16.0

21.9

3.9

4.7

13.2

11.1

Platelets, 103/ml [range: 150–450]

174

180

240

179

180

176

Urea, mg/dl [range: 19–44.1]

59.9

44.9

64.2

59.9

29.96

 

Creatinine, mg/dl [range: 0.8–1.25]

1.48

1.22

1.77

1.28

0.69

 

Na, mEq/L [range: 135–145]

133

133

167

148

140

138

K, mEq/L [range: 3.5–5.1]

4.8

4.4

4.2

4.7

4.5

3.5

AST, U/l [range: 05–34]

23

26

22

   

ALT, U/l [range: 00–55]

15

17

21

   

CRP, mg/ml [range: < 0.5]

0.37

0.68

5.94

1.08

1.94

0.37

  1. HbA1c—6.6 %
  2. SARS-CoV-2 rRT-PCR positive
  3. Na: Sodium, K: Potassium, AST: Aspartate Transaminase, ALT: Alanine Transaminase, CRP: c-reactive protein, HbA1c: Glycosylated hemoglobin, SARS-CoV-2 rRT-PCR: severe acute respiratory syndrome Coronavirus 2 recombinant reverse transcriptase polymerase chain reaction